Pulmonary Embolism Treatment
Patients with Pulmonary embolism may be divided into low, moderate, or high risk categories depending on the severity of their symptoms. Moderate and high-risk PE are also known as submassive- and massive-PE. While treatment options for low-risk PE are well determined (anticoagulation), treatment for moderate or high-risk categories is less clear-cut and, thus, often debated. This has led to an absence in a standard process or consensus for clinicians. Furthermore, the urgency in many of these cases intensifies the already challenging decision-making process.